ChordexBio operates at the intersection of artificial intelligence and biology, developing platforms and tools that make intelligent systems accessible to researchers, institutions, and students across the Philippines and beyond.
Since its founding in 2025, we have developed flagship technologies and a range of platforms and enablement tools across the biotechnology sector. ChordexBio is among the first in the Philippines and an early mover globally in building AI-native platforms across the full biology stack.
Through our innovation, we provide capabilities to researchers worldwide through our platforms, training, partnerships, technology transfer, and open research programs.
Build and deploy production-grade AI and computational-biology platforms that address real problems in genomics, oncology, biotechnology, and programmable biology.
Democratize access to tools and training so expertise is built and retained in the region, not just exported.
Adopt and advance AI × Biology innovation from a Philippine base — contributing Filipino-built solutions to a global challenge space.
Uphold responsible science, ensuring inclusive access, open collaboration, technology transfer, and evidence-based methodology throughout.
We organize our work the way our partners experience it — as solvable problems in data, intelligence, and biology.
ChordexBio is among the first in the Philippines and an early mover globally to build AI-native platforms across the full biology stack — from genome-based cryptography (HugeCrypt and DNAcrypt-AI) to machine-learning whole-genome analysis (Covary) to a trainable, Filipino-built CRISPR targetability engine (guntingAI) that generalizes beyond well-annotated model organisms to non-model, unannotated, and underserved genomes.
Our AI × Biology work is not a single product line — it is the core of how we build, and it is built from a Philippine base for a global audience.